Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q1 2023 Earnings Presentation
15 slides from Nolato Ab Class B's earnings presentation, May 3, 2023
Slide 1: First quarter
Medical Solutions First quarter Integrated Solutions CEO Christer Wahlquist CFO Per-Ola Holmström Industrial Solutions May 3, 2023
Slide 2: Q1 summary
Q1 summary A global solutions provider established on three continents Group Growth across Group ● Sales totaled SEK 2,476 million (2,879) SEKm - Positive currency effect; a 20% decrease, adjusted for currency 12000 Balancing - Strong growth for Medical Solutions - Lower volumes for Integrated Solut
Slide 3: One Group – three business areas
One Group – three business areas Nolato Medical Solutions Integrated Solutions Industrial Solutions Our offering as a strategic partner for selected Development and manufacture of Design, development and Development and manufacture of global customers comprises development and complex product system
Slide 4: Medical Solutions – Sustainable Growth and Global expansion
Medical Solutions – Sustainable Growth and Global expansion SEKm 5500 5000 4500 4000 3500 3000 132 EBITA 2500 2000 1 324 SEKm, Q1 1500 1000 10.0 SALES SEKm, Q1 500 EBITA-MARGIN 0 %, Q1 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 4
Slide 5: Medical Solutions – Focused product areas
Medical Solutions – Focused product areas Pharma Diagnostics Medical Devices Drug Delivery ~14% In Vitro Diagnostics (IVD) ~15% Endoscopy & General Surgery ~22% Cardiology ~8% Continence care ~11% Pharma Packaging ~13% Other ~17% 5
Slide 6: Medical Solutions – Q1
Medical Solutions – Q1 Q1 Full year ● 22% increase in sales SEKm 2023 2022 2022 2021 - A strong increase of 13%, adjusted for currency - Good growth in most market areas Sales 1 324 1 088 4,859 4,067 - IVD at unchanged level ● EBITA margin of 10.0% (9.7) Operating profit (EBITA) 132 106 457 457 EBIT
Slide 7: Integrated Solutions – Expansion into new market segments
Integrated Solutions – Expansion into new market segments SEKm 5500 5000 4500 4000 3500 22 EBITA 3000 2500 414 SEKm, Q1 2000 1500 5.3 SALES 1000 SEKm, Q1 500 EBITA-MARGIN %, Q1 0 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 7
Slide 8: Integrated Solutions – Focused product areas
Integrated Solutions – Focused product areas Consumer Electronics EMC & Thermal Trishield - Dispensing Gaskets Complex Modules Speakers Compashield - Extrusion & Molded Gaskets VHP MIL SPEC EMI Shielding In/On/Over Ear Headphones - Aerospace & Defence Wearable & Handheld Wellbeing Devices Thermal In
Slide 9: Integrated Solutions – Q1
Integrated Solutions – Q1 Q1 Full year ● 64% decrease in sales - A decrease of some 66%, adjusted for currency SEKm 2023 2022 2022 2021 - Consumer electronics volumes as previously announced - Change in sourcing strategy of a significant customer is having negative effect Sales 414 1 140 3,311 5,226
Slide 10: Industrial Solutions – Technological and geographical expansion
Industrial Solutions – Technological and geographical expansion MSEK 2800 2600 2400 2200 2000 1800 46 1600 1400 1200 740 EBITA SEKm, Q1 1000 800 6.2 SALES 600 SEKm, Q1 400 EBITA-MARGIN 200 %, Q1 0 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 10
Slide 11: Industrial Solutions – Focused product areas
Industrial Solutions – Focused product areas Domestic appliances Packaging Hygiene Gardening/forestry Furniture sectors Automotive Other selected industrial segments 11
Slide 12: Industrial Solutions – Q1
Industrial Solutions – Q1 ● 13% increase in sales Q1 Full year - 7% increase, adjusted for currency SEKm 2023 2022 2022 2021 - Automotive volumes increased * Supply chain disruptions had less of an impact than previously Sales 740 653 2,618 2,324 - The charging on of cost increases contributed less
Slide 13: Group financial highlights
Group financial highlights Q1 Full year SEKm 2023 2022 2022 2021 Net sales 2,476 2,879 10,774 11,610 Operating profit (EBITA) 193 267 908 1,369 Operating profit (EBITA), excl. a non-recurring item in 2021* 193 267 908 1,319 EBITA margin (%), excl. a non-recurring item in 2021* 7.8 9.3 8.4 11.4 Profi
Slide 14: Current situation
Current situation Medical Solutions Integrated Solutions Industrial Solutions • Maintained growth strategy • Established position in new product • Advanced market positions areas • Focus on innovation • Emphasis on sustainable solutions • Strong customer relationships • Flexible production structure
Slide 15: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini